Trial Profile
Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction(KSCC 1601)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jan 2021
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms KSCC 1601
- 07 Jan 2021 Status changed from active, no longer recruiting to completed.
- 06 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 21 Jul 2017 New trial record